13 Sep 2023
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-13-2023-60327.pdf
15 Mar 2023
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-15-2023-86840.pdf
27 Nov 2021
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/news/initiator-approval-trial-pain-reducing-effects/
19 Dec 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/averitas-pharma-announces-fda-acceptance-of-snda-filing-for-qutenza-capsaicin-8-patch-for-the-treatment-of-neuropathic-pain-associated-with-diabetic-peripheral-neuropathy-300976908.html
18 Dec 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/averitas-pharma-announces-fda-acceptance-of-snda-filing-for-qutenza-capsaicin-8-patch-for-the-treatment-of-neuropathic-pain-associated-with-diabetic-peripheral-neuropathy-300976908.html
03 Dec 2019
// GLOBE NEWSWIRE
https://www.globenewswire.com/news-release/2019/12/03/1955486/0/en/Centrexion-Therapeutics-Announces-Issuance-of-U-S-Composition-of-Matter-Patent-for-Lead-Pipeline-Candidate-CNTX-4975.html
LOOKING FOR A SUPPLIER?